US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tourmaline Bio

16.76

+0.75004.68%

Post-market: 16.760.00000.00%19:36 EDT

Volume:439.18K

Turnover:7.32M

Market Cap:430.49M

PE:-5.80

High:17.20

Open:15.84

Low:15.49

Close:16.01

Loading ...

Overview Company News Filings

Tourmaline Bio Inc Q4 Shr Loss $0.86

THOMSON REUTERS

Tourmaline Bio Inc: Expected Cash Runway Into Second Half of 2027

THOMSON REUTERS

Press Release: Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Tourmaline Bio Initiated at Outperform by Wedbush

Tourmaline Bio Inc : Wedbush Initiates Coverage With Outperform Rating; Price Target $42

THOMSON REUTERS

Wedbush Initiates Tourmaline Bio at Outperform With $42 Price Target

MT Newswires Live

Tourmaline Bio initiated with an Outperform at Wedbush

Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025

Tourmaline Bio Initiated at Outperform by LifeSci Capital

Tourmaline Bio management to meet with Truist

Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference

Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker

Tourmaline Bio: Promising Cardiovascular and Innovative Indications Drive Buy Rating Amid Upcoming Data Milestones

Truist Financial Sticks to Its Buy Rating for Tourmaline Bio (TRML)

Tourmaline Bio Price Target Maintained With a $49.00/Share by HC Wainwright & Co.

Tourmaline Bio Updates on Clinical Progress and Outlook

Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day

Tourmaline Bio to host investor day

BMO Capital Initiates Tourmaline Bio at Outperform With $50 Price Target

MT Newswires Live

Analysts’ Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TRML/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRML","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRML\",,,,,undefined,":{"symbol":"TRML","market":"US","secType":"STK","nameCN":"Tourmaline Bio","latestPrice":16.76,"timestamp":1745265600000,"preClose":16.01,"halted":0,"volume":439179,"hourTrading":{"tag":"盘后","latestPrice":16.76,"preClose":16.76,"latestTime":"19:36 EDT","volume":1107,"amount":18542.89,"timestamp":1745278588208},"delay":0,"floatShares":15578030,"shares":25685429,"eps":-2.888196,"marketStatus":"Closed","change":0.75,"latestTime":"04-21 16:00:00 EDT","open":15.84,"high":17.2,"low":15.49,"amount":7324779.757112999,"amplitude":0.106808,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.888196,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":5,"adr":0,"listingDate":1620360000000,"exchange":"NASDAQ","adjPreClose":16.01,"preHourTrading":{"tag":"盘前","latestPrice":15.82,"preClose":16.01,"latestTime":"09:29 EDT","volume":447,"amount":7275.049266,"timestamp":1745242199999},"postHourTrading":{"tag":"盘后","latestPrice":16.76,"preClose":16.76,"latestTime":"19:36 EDT","volume":1107,"amount":18542.89,"timestamp":1745278588208},"volumeRatio":1.391327,"impliedVol":1.1898,"impliedVolPercentile":0.872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRML\",,,,,undefined,":{"symbol":"TRML","floatShares":15578030,"roa":"-21.60%","roe":"-28.99%","lyrEps":-2.888196,"volumeRatio":1.391327,"shares":25685429,"dividePrice":0,"high":17.2,"amplitude":0.106808,"preClose":16.01,"low":15.49,"week52Low":11.56,"pbRate":"1.43","week52High":29.7883,"institutionHeld":0,"latestPrice":16.76,"eps":-2.888196,"divideRate":0,"volume":439179,"delay":0,"ttmEps":-2.888196,"open":15.84,"prevYearClose":20.28,"prevWeekClose":16.01,"prevMonthClose":15.21,"prevQuarterClose":15.21,"fiveDayClose":13.1,"twentyDayClose":17.15,"sixtyDayClose":17.51},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRML\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519683898","title":"Tourmaline Bio Inc Q4 Shr Loss $0.86","url":"https://stock-news.laohu8.com/highlight/detail?id=2519683898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519683898?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:31","pubTimestamp":1741865464,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW04Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRML"],"gpt_icon":0},{"id":"2519389848","title":"Tourmaline Bio Inc: Expected Cash Runway Into Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2519389848","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519389848?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:31","pubTimestamp":1741865464,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW04Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRML","BK4139"],"gpt_icon":0},{"id":"2519083894","title":"Press Release: Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2519083894","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519083894?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:30","pubTimestamp":1741865400,"startTime":"0","endTime":"0","summary":"-- Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease over-enrolled to 143 total participants, on track to report topline data in the second quarter of 2025 --. -- Cardiovascular Scientific Advisory Board strengthened with recent appointments of Drs. Deepak L. Bhatt, Dipender Gill, Paul M. Ridker, and Tabassome Simon --. -- Cash, cash equivalents, and investments of $294.9 million as of December 31, 2024, providing expected cash runway into the second half of 2027 --. \"2024 was an important year of execution as it relates to our clinical development programs in cardiovascular inflammation and thyroid eye disease,\" said Sandeep Kulkarni, MD, Co-Founder and Chief Executive Officer of Tourmaline. \"We are now transitioning into a potentially transformative year of data in 2025, leading off with topline data from our Phase 2 TRANQUILITY trial expected in the second quarter. Complemented by our strong balance sheet and with the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","AAA","BK4139"],"gpt_icon":0},{"id":"2517163896","title":"Tourmaline Bio Initiated at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2517163896","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517163896?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:18","pubTimestamp":1741270680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRML/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2025 09:18 ET (14:18 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML"],"gpt_icon":0},{"id":"2517801159","title":"Tourmaline Bio Inc : Wedbush Initiates Coverage With Outperform Rating; Price Target $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2517801159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517801159?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:14","pubTimestamp":1741263270,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRML","BK4139"],"gpt_icon":0},{"id":"2517156294","title":"Wedbush Initiates Tourmaline Bio at Outperform With $42 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2517156294","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517156294?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:06","pubTimestamp":1741262786,"startTime":"0","endTime":"0","summary":"Tourmaline Bio (TRML) has an average rating of buy and mean price target of $57.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRML"],"gpt_icon":0},{"id":"2517156978","title":"Tourmaline Bio initiated with an Outperform at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2517156978","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517156978?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:01","pubTimestamp":1741262489,"startTime":"0","endTime":"0","summary":"Wedbush initiated coverage of Tourmaline Bio (TRML) with an Outperform rating and $42 price target Published first on TheFly – the ultimate source ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tourmaline-bio-initiated-with-an-outperform-at-wedbush?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tourmaline-bio-initiated-with-an-outperform-at-wedbush?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRML"],"gpt_icon":0},{"id":"2516443680","title":"Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516443680","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516443680?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:15","pubTimestamp":1741004100,"startTime":"0","endTime":"0","summary":"NEW YORK, March  03, 2025  (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035493/0/en/Tourmaline-Bio-to-Present-at-the-Leerink-Partners-Global-Healthcare-Conference-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","HCSG","BK4139","BK4137"],"gpt_icon":0},{"id":"2514729775","title":"Tourmaline Bio Initiated at Outperform by LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2514729775","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514729775?lang=en_us&edition=fundamental","pubTime":"2025-02-25 00:16","pubTimestamp":1740413760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRML/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2025 11:16 ET (16:16 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML"],"gpt_icon":0},{"id":"2512436277","title":"Tourmaline Bio management to meet with Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2512436277","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512436277?lang=en_us&edition=fundamental","pubTime":"2025-02-20 03:55","pubTimestamp":1739994908,"startTime":"0","endTime":"0","summary":"Group Dinner Meeting to be held in New York on February 24 at 6 pm hosted by Truist. Published first on TheFly – the ultimate source for real-time,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tourmaline-bio-management-to-meet-with-truist-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tourmaline-bio-management-to-meet-with-truist-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRML"],"gpt_icon":0},{"id":"2506837654","title":"Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2506837654","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506837654?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:00","pubTimestamp":1737979200,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 27, 2025  -- Tourmaline Bio, Inc.  , a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, today announced thatSandeep Kulkarni, MD, Co-Founder and Chief Executive Officer, is expected to participate in the following investor conference:. Guggenheim Securities SMID Cap Biotech Conference, New YorkFireside ChatWednesday, February 5, 2025,at1:30 pm ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tourmaline-bio-present-guggenheim-securities-120000523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","TRML","BK4011","SMID"],"gpt_icon":0},{"id":"2502585745","title":"Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker","url":"https://stock-news.laohu8.com/highlight/detail?id=2502585745","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502585745?lang=en_us&edition=fundamental","pubTime":"2025-01-10 20:30","pubTimestamp":1736512200,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 10, 2025  -- Tourmaline Bio, Inc.  , a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, today announced that Paul M. Ridker, MD, MPH, Eugene Braunwald Professor of Medicine at the Harvard Medical School and Director of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital, has joined Tourmaline’s Cardiovascular Scientific Advisory Board .“Dr. Ridker is a world-renowned pioneer in inflammation and cardiovascular disease whose ground-breaking work bridges population science, translational research, and clinical trials,” said Emil deGoma, MD, Senior Vice President of Medical Research at Tourmaline. “We are grateful to have his expert guidance as we adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tourmaline-strengthens-cardiovascular-scientific-advisory-123000048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AAA","BK4139","CSII","BK4082","TRML"],"gpt_icon":0},{"id":"2501724199","title":"Tourmaline Bio: Promising Cardiovascular and Innovative Indications Drive Buy Rating Amid Upcoming Data Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2501724199","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501724199?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:16","pubTimestamp":1736342188,"startTime":"0","endTime":"0","summary":"Jefferies analyst Roger Song maintained a Buy rating on Tourmaline Bio (TRML – Research Report) yesterday and set a price target of $64.00. Roger S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tourmaline-bio-promising-cardiovascular-and-innovative-indications-drive-buy-rating-amid-upcoming-data-milestones?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tourmaline-bio-promising-cardiovascular-and-innovative-indications-drive-buy-rating-amid-upcoming-data-milestones?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSII","TRML"],"gpt_icon":0},{"id":"2490485974","title":"Truist Financial Sticks to Its Buy Rating for Tourmaline Bio (TRML)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490485974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490485974?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:56","pubTimestamp":1733921814,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on Tourmaline Bio (TRML – Research Report) today. The company’s shares closed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-buy-rating-for-tourmaline-bio-trml-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":"63f8184153426c71b846b9d563441620","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-buy-rating-for-tourmaline-bio-trml-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRML"],"gpt_icon":0},{"id":"2490085914","title":"Tourmaline Bio Price Target Maintained With a $49.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2490085914","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490085914?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:51","pubTimestamp":1733921460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRML/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2024 07:51 ET (12:51 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML"],"gpt_icon":0},{"id":"2490902196","title":"Tourmaline Bio Updates on Clinical Progress and Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2490902196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490902196?lang=en_us&edition=fundamental","pubTime":"2024-12-11 05:32","pubTimestamp":1733866321,"startTime":"0","endTime":"0","summary":"An announcement from Tourmaline Bio ( ($TRML) ) is now available. Tourmaline Bio has released an updated corporate presentation detailing its progr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tourmaline-bio-updates-on-clinical-progress-and-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tourmaline-bio-updates-on-clinical-progress-and-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PRGS","BK4097","TRML","LU2065732104.USD"],"gpt_icon":0},{"id":"2490401367","title":"Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2490401367","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490401367?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:30","pubTimestamp":1733837400,"startTime":"0","endTime":"0","summary":"– Phase 2 TRANQUILITY trial surpasses enrollment target, with 143 total patients enrolled; topline data expected in second quarter of 2025 – – Deepak L. Bhatt, MD, MPH, MBA and Dipender Gill, MD, PhD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994544/0/en/Tourmaline-Bio-Highlights-Cardiovascular-Inflammation-Focus-and-Announces-Key-Clinical-and-Strategic-Updates-at-Investor-Day.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAA","BK4139","TRML","CSII","BK4082"],"gpt_icon":0},{"id":"2490768928","title":"Tourmaline Bio to host investor day","url":"https://stock-news.laohu8.com/highlight/detail?id=2490768928","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490768928?lang=en_us&edition=fundamental","pubTime":"2024-12-09 06:35","pubTimestamp":1733697304,"startTime":"0","endTime":"0","summary":"Investor Day to be held on December 10 at 10 am. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tourmaline-bio-to-host-investor-day?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tourmaline-bio-to-host-investor-day?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRML","BK4139"],"gpt_icon":0},{"id":"2489541082","title":"BMO Capital Initiates Tourmaline Bio at Outperform With $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2489541082","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489541082?lang=en_us&edition=fundamental","pubTime":"2024-12-06 21:57","pubTimestamp":1733493454,"startTime":"0","endTime":"0","summary":"Tourmaline Bio (TRML) has an average rating of buy and mean price target of $57.29, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRML","BMO"],"gpt_icon":0},{"id":"2485251842","title":"Analysts’ Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485251842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485251842?lang=en_us&edition=fundamental","pubTime":"2024-11-22 19:51","pubTimestamp":1732276306,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neumora Therapeutics, Inc. (NMRA – Research Report),...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-neumora-therapeutics-inc-nmra-tourmaline-bio-trml?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-neumora-therapeutics-inc-nmra-tourmaline-bio-trml?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","BK4139","NMRA","BK4007","TRML"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRML\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-13","symbol":"TRML","fiscalQuarterEnding":"2024/12","expectedEps":-0.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.86},{"market":"US","date":"2024-11-07","symbol":"TRML","fiscalQuarterEnding":"2024/09","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.78},{"market":"US","date":"2024-08-08","symbol":"TRML","fiscalQuarterEnding":"2024/06","expectedEps":-0.72,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-05-13","symbol":"TRML","fiscalQuarterEnding":"2024/03","expectedEps":-0.68,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-03-19","symbol":"TRML","fiscalQuarterEnding":"2023/12","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710820800000,"reportTimeType":"pre","actualEps":-0.81}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRML\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRML\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRML\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRML","date":"2025-04-17","current":-5.094283,"percent":0.951149,"low":-34.281816,"twenty":-14.285835,"median":-9.637837,"eighty":-7.153081,"high":-4.245235,"avg":-11.864754,"sd":6.867392,"marketCap":372952429},"quantilePoints":[{"date":"2023-10-27","current":-8.71976,"twenty":-8.71976,"median":-8.71976,"eighty":-8.71976,"marketCap":266004990},{"date":"2023-11-03","current":-11.48635,"twenty":-11.479684,"median":-10.446378,"eighty":-9.333076,"marketCap":350402598},{"date":"2023-11-10","current":-10.793036,"twenty":-11.186358,"median":-10.579708,"eighty":-9.899727,"marketCap":329252354},{"date":"2023-11-17","current":-10.986364,"twenty":-10.99303,"median":-10.829702,"eighty":-10.326382,"marketCap":335150019},{"date":"2023-11-24","current":-11.615227,"twenty":-11.031696,"median":-10.76637,"eighty":-10.248203,"marketCap":396567073},{"date":"2023-12-01","current":-11.168487,"twenty":-11.229245,"median":-10.866367,"eighty":-10.342382,"marketCap":381314493},{"date":"2023-12-08","current":-10.870661,"twenty":-11.3174,"median":-10.953031,"eighty":-10.4513,"marketCap":371146107},{"date":"2023-12-15","current":-11.376966,"twenty":-11.3174,"median":-10.971922,"eighty":-10.506121,"marketCap":388432364},{"date":"2023-12-22","current":-11.990488,"twenty":-11.334079,"median":-11.000345,"eighty":-10.56642,"marketCap":409379240},{"date":"2023-12-29","current":-16.463839,"twenty":-11.448127,"median":-11.049357,"eighty":-10.624611,"marketCap":562108405},{"date":"2024-01-05","current":-15.832448,"twenty":-11.615227,"median":-11.12977,"eighty":-10.691965,"marketCap":540551426},{"date":"2024-01-12","current":-17.86958,"twenty":-14.057403,"median":-11.275705,"eighty":-10.739704,"marketCap":610103190},{"date":"2024-01-19","current":-18.042319,"twenty":-15.794326,"median":-11.3174,"eighty":-10.78237,"marketCap":616000854},{"date":"2024-01-26","current":-28.247663,"twenty":-17.245336,"median":-11.3174,"eighty":-10.802718,"marketCap":964431710},{"date":"2024-02-02","current":-25.696339,"twenty":-18.466423,"median":-11.376966,"eighty":-10.854121,"marketCap":877324413},{"date":"2024-02-09","current":-27.221144,"twenty":-19.414702,"median":-11.483017,"eighty":-10.869802,"marketCap":929384294},{"date":"2024-02-16","current":-29.594731,"twenty":-25.820542,"median":-11.615227,"eighty":-10.931224,"marketCap":1010423322},{"date":"2024-02-23","current":-27.386394,"twenty":-26.713376,"median":-11.990488,"eighty":-10.954365,"marketCap":935026252},{"date":"2024-03-01","current":-29.159073,"twenty":-27.368366,"median":-15.618013,"eighty":-10.967032,"marketCap":995549070},{"date":"2024-03-08","current":-31.036911,"twenty":-27.583191,"median":-15.832448,"eighty":-10.980587,"marketCap":1059662225},{"date":"2024-03-15","current":-31.337365,"twenty":-27.849093,"median":-16.776557,"eighty":-10.990364,"marketCap":1069920330},{"date":"2024-03-22","current":-17.418731,"twenty":-27.849093,"median":-17.86958,"eighty":-11.001809,"marketCap":733746622},{"date":"2024-03-28","current":-13.942291,"twenty":-27.737925,"median":-17.089275,"eighty":-11.024339,"marketCap":587305056},{"date":"2024-04-05","current":-13.369987,"twenty":-27.649291,"median":-16.097513,"eighty":-11.066035,"marketCap":563197337},{"date":"2024-04-12","current":-12.237556,"twenty":-27.601219,"median":-15.641839,"eighty":-11.122026,"marketCap":515494830},{"date":"2024-04-19","current":-9.534335,"twenty":-27.587698,"median":-14.761172,"eighty":-11.024339,"marketCap":401624330},{"date":"2024-04-26","current":-9.741339,"twenty":-27.562159,"median":-14.331944,"eighty":-10.964588,"marketCap":410344144},{"date":"2024-05-03","current":-9.692632,"twenty":-27.499064,"median":-13.999847,"eighty":-10.868085,"marketCap":408292423},{"date":"2024-05-10","current":-9.601307,"twenty":-27.413435,"median":-13.936202,"eighty":-10.711061,"marketCap":404445446},{"date":"2024-05-17","current":-8.025737,"twenty":-27.374376,"median":-13.351722,"eighty":-10.398841,"marketCap":384697635},{"date":"2024-05-24","current":-7.308771,"twenty":-27.302266,"median":-12.267998,"eighty":-9.914031,"marketCap":350331312},{"date":"2024-05-31","current":-7.233864,"twenty":-27.215971,"median":-12.121878,"eighty":-9.653666,"marketCap":346740801},{"date":"2024-06-07","current":-7.255266,"twenty":-27.185428,"median":-11.76414,"eighty":-9.572083,"marketCap":347766662},{"date":"2024-06-14","current":-8.881815,"twenty":-27.14603,"median":-11.588489,"eighty":-9.467363,"marketCap":425732049},{"date":"2024-06-21","current":-8.084592,"twenty":-27.109976,"median":-11.483017,"eighty":-9.430834,"marketCap":387518750},{"date":"2024-06-28","current":-7.0787,"twenty":-26.971767,"median":-11.440238,"eighty":-9.386998,"marketCap":339303314},{"date":"2024-07-05","current":-6.86468,"twenty":-26.454986,"median":-11.350161,"eighty":-9.074433,"marketCap":329044710},{"date":"2024-07-12","current":-7.597697,"twenty":-26.409918,"median":-11.3174,"eighty":-8.662445,"marketCap":364180427},{"date":"2024-07-15","current":-7.977582,"twenty":-26.391406,"median":-11.3174,"eighty":-8.3885,"marketCap":382389449},{"date":"2024-08-02","current":-8.742702,"twenty":-26.372893,"median":-11.3174,"eighty":-8.456986,"marketCap":419063957},{"date":"2024-08-09","current":-7.563763,"twenty":-26.068949,"median":-11.287618,"eighty":-8.103854,"marketCap":372825418},{"date":"2024-08-16","current":-7.111185,"twenty":-25.449967,"median":-11.168487,"eighty":-7.996844,"marketCap":350517432},{"date":"2024-08-23","current":-7.407701,"twenty":-24.869472,"median":-11.028509,"eighty":-7.771053,"marketCap":365133009},{"date":"2024-08-30","current":-8.968313,"twenty":-24.475141,"median":-10.986364,"eighty":-7.803156,"marketCap":442057098},{"date":"2024-09-06","current":-8.32326,"twenty":-24.06836,"median":-10.959698,"eighty":-7.825628,"marketCap":410261808},{"date":"2024-09-13","current":-9.264829,"twenty":-22.445383,"median":-10.872215,"eighty":-7.866292,"marketCap":456672675},{"date":"2024-09-20","current":-11.756605,"twenty":-20.29746,"median":-10.870661,"eighty":-7.979091,"marketCap":579494803},{"date":"2024-09-27","current":-12.927063,"twenty":-19.046589,"median":-10.935322,"eighty":-7.99325,"marketCap":637187870},{"date":"2024-10-04","current":-13.655348,"twenty":-18.735659,"median":-10.971922,"eighty":-8.030017,"marketCap":673085778},{"date":"2024-10-11","current":-14.295199,"twenty":-18.642737,"median":-11.000345,"eighty":-8.047139,"marketCap":704624655},{"date":"2024-10-18","current":-15.153535,"twenty":-18.505737,"median":-11.091052,"eighty":-8.05463,"marketCap":746932904},{"date":"2024-10-25","current":-14.22237,"twenty":-18.394945,"median":-11.231032,"eighty":-8.094223,"marketCap":701034864},{"date":"2024-10-31","current":-13.774995,"twenty":-18.161449,"median":-11.308466,"eighty":-8.132746,"marketCap":678983292},{"date":"2024-11-08","current":-11.103216,"twenty":-18.042319,"median":-11.3174,"eighty":-8.159499,"marketCap":709240100},{"date":"2024-11-15","current":-10.790634,"twenty":-17.86958,"median":-11.3174,"eighty":-8.214017,"marketCap":689273356},{"date":"2024-11-22","current":-9.120655,"twenty":-17.418731,"median":-11.275705,"eighty":-8.320014,"marketCap":582600099},{"date":"2024-11-29","current":-10.453427,"twenty":-17.155166,"median":-11.168487,"eighty":-8.322611,"marketCap":667733564},{"date":"2024-12-06","current":-9.646538,"twenty":-16.588926,"median":-11.070204,"eighty":-8.356553,"marketCap":616191918},{"date":"2024-12-13","current":-9.040368,"twenty":-16.38283,"median":-10.99303,"eighty":-8.47724,"marketCap":577471577},{"date":"2024-12-20","current":-8.165235,"twenty":-15.938474,"median":-10.96581,"eighty":-8.356553,"marketCap":521570687},{"date":"2024-12-27","current":-8.76739,"twenty":-15.803856,"median":-10.935322,"eighty":-8.34823,"marketCap":560034602},{"date":"2025-01-03","current":-8.285666,"twenty":-15.727613,"median":-10.872215,"eighty":-8.294497,"marketCap":529263470},{"date":"2025-01-10","current":-8.028746,"twenty":-15.632309,"median":-10.835753,"eighty":-8.286469,"marketCap":512852200},{"date":"2025-01-17","current":-6.956908,"twenty":-15.506057,"median":-10.790634,"eighty":-8.144818,"marketCap":444386431},{"date":"2025-01-24","current":-7.029167,"twenty":-15.153535,"median":-10.691965,"eighty":-8.084592,"marketCap":449002101},{"date":"2025-01-31","current":-6.583572,"twenty":-15.019926,"median":-10.527506,"eighty":-8.028746,"marketCap":420538804},{"date":"2025-02-07","current":-6.017545,"twenty":-14.820605,"median":-10.47753,"eighty":-7.976559,"marketCap":384382723},{"date":"2025-02-14","current":-5.254814,"twenty":-14.737372,"median":-10.453427,"eighty":-7.815984,"marketCap":335661764},{"date":"2025-02-21","current":-4.965779,"twenty":-14.726968,"median":-10.377826,"eighty":-7.723969,"marketCap":317199085},{"date":"2025-02-28","current":-5.134383,"twenty":-14.722286,"median":-10.300881,"eighty":-7.572086,"marketCap":327968981},{"date":"2025-03-07","current":-5.752596,"twenty":-14.70512,"median":-10.18045,"eighty":-7.459722,"marketCap":367458601},{"date":"2025-03-14","current":-5.978414,"twenty":-14.542126,"median":-10.060741,"eighty":-7.427006,"marketCap":437679710},{"date":"2025-03-21","current":-5.922279,"twenty":-14.497547,"median":-9.979906,"eighty":-7.330173,"marketCap":433570041},{"date":"2025-03-28","current":-5.869652,"twenty":-14.468597,"median":-9.843242,"eighty":-7.305561,"marketCap":429717227},{"date":"2025-04-04","current":-4.603098,"twenty":-14.357888,"median":-9.76419,"eighty":-7.260688,"marketCap":336992828},{"date":"2025-04-11","current":-4.245235,"twenty":-14.302548,"median":-9.646538,"eighty":-7.232265,"marketCap":310793690},{"date":"2025-04-17","current":-5.094283,"twenty":-14.285835,"median":-9.637837,"eighty":-7.153081,"marketCap":372952429}],"updateTime":1745260315248}}}